Literature DB >> 33283529

Small cell glioblastoma multiforme: a case series and clinicopathological update.

Arun Kumar Yadav1, Renu Madan1, Debajyoti Chatterjee2, Shalin Dhiman1, Shikha Goyal1, Narendra Kumar1, Sushanta Kumar Sahoo3.   

Abstract

Small cell glioblastoma (scGBM) is a rare histological variant of classical glioblastoma (GBM). Presence of necrosis and microvascular proliferation is not essential for the diagnosis. It is thought to have more aggressive behavior as compared with classical GBM; however, because of its rarity standard treatment guidelines are not available. Adjuvant treatment for these cancers consists of postoperative radiotherapy with concurrent and maintenance temozolomide similar to classical GBM. Here we present a case series of five small cell glioblastoma patients along with the clinical-pathological review.

Entities:  

Keywords:  concurrent chemotherapy; glioblastoma multiforme; glioma; high grade; immunohistochemistry; pathology; prognosis; radiotherapy; small cell; temozolomide

Year:  2020        PMID: 33283529     DOI: 10.2217/cns-2020-0016

Source DB:  PubMed          Journal:  CNS Oncol        ISSN: 2045-0907


  1 in total

1.  Dramatic clinical response in the treatment of small cell glioblastoma multiforme.

Authors:  Farzana Yasmin Zaman; Catriona McLean; Malaka Ameratunga
Journal:  J Clin Pharm Ther       Date:  2022-01-11       Impact factor: 2.145

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.